These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 213948)

  • 21. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [PTH, thyrocalcitonin (author's transl)].
    Takuwa Y; Ogata E
    Nihon Rinsho; 1981 Sep; 39(9):2975-81. PubMed ID: 6279928
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of acetazolamide on the urinary excretion of cyclic AMP and on the activity of renal adenyl cyclase.
    Rodriguez HJ; Walls J; Yates J; Klahr S
    J Clin Invest; 1974 Jan; 53(1):122-30. PubMed ID: 4357608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of synthetic human parathyroid hormone (1-34) on plasma and urinary adenosine 3',5'-monophosphate and urinary phosphate and calcium in patients with hypoparathyroidism and pseudohypoparathyroidism (author's transl)].
    Konagaya Y; Takatsuki K; Tomita A
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1591-608. PubMed ID: 6276237
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parathyroid hormone loading test].
    Furukawa Y
    Nihon Rinsho; 1979 Jun; Suppl():2526-7. PubMed ID: 226749
    [No Abstract]   [Full Text] [Related]  

  • 26. [Investigations of the urinary cAMP-excretion in pseudohypoparathyroidism (author's transl)].
    Stögmann W
    Padiatr Padol Suppl; 1977; (5):63-9. PubMed ID: 199875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism.
    Mallette LE; Kirkland JL; Gagel RF; Law WM; Heath H
    J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased urinary phosphate excretion in pseudohypoparathyroidism type II with long-term treatment with phosphodiesterase inhibitor.
    Mano T; Uchimura K; Hayashi R; Kobahashi T; Fujiwara K; Makino M; Kakizawa H; Nagata M; Nakai A; Wada M; Nagasaka A; Itoh M
    Horm Metab Res; 1999 Nov; 31(11):602-5. PubMed ID: 10598827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudohypoparathyroidism. An update.
    Attanasio R; Giusti M; Lomeo A; Monachesi M; Nalin R; Giordano G
    Minerva Endocrinol; 1987; 12(1):19-27. PubMed ID: 3035357
    [No Abstract]   [Full Text] [Related]  

  • 30. Pseudohypoparathyroidism type II: restoration of normal renal responsiveness to parathyroid hormone by calcium administration.
    Rodriguez HJ; Villarreal H; Klahr S; Slatopolsky E
    J Clin Endocrinol Metab; 1974 Oct; 39(4):693-701. PubMed ID: 4370302
    [No Abstract]   [Full Text] [Related]  

  • 31. Pseudotumor cerebri in pseudohypoparathyroidism.
    Asplund J
    Acta Med Scand; 1980; 208(4):331-2. PubMed ID: 6255754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular cyclic nucleotides.
    Broadus AE; Hardman JG; Kaminsky NI; Ball JH; Sutherland EW; Liddle GW
    Ann N Y Acad Sci; 1971 Dec; 185():50-66. PubMed ID: 4330516
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of intravenous calcium on urinary cyclic adenosine-3',5'-monophosphate and hydroxyproline in children with hypoparathyroidism.
    Kruse K; Kracht U
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):217-22. PubMed ID: 6291297
    [No Abstract]   [Full Text] [Related]  

  • 34. Normocalcemic pseudohypoparathyroidism (Type II).
    Patel ZM; Ambani LM; Shah P; Sheth AR; Merchant SM
    Indian Pediatr; 1981 Nov; 18(11):828-32. PubMed ID: 6281182
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of serum and urinary cyclic AMP and GMP].
    Kimura H
    Nihon Rinsho; 1976; 34 suppl():2369-70. PubMed ID: 186652
    [No Abstract]   [Full Text] [Related]  

  • 36. [Investigation of cyclic renal adenosinmonophosphate (yamp)-excretion in pseudohypoparathyreoidism (author's transl)].
    Zabransky S
    Klin Padiatr; 1975 May; 187(3):271-3. PubMed ID: 171472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn urinary cyclic AMP and developmental renal responsiveness to parathyroid hormone.
    Linarelli LG
    Pediatrics; 1972 Jul; 50(1):14-23. PubMed ID: 4338860
    [No Abstract]   [Full Text] [Related]  

  • 38. [Histomorphometric data in 5 cases of pseudohypoparathyroidism: discussion on bone sensitivity to parathyroid hormone].
    Duquesnoy B; Wemeau JL; Hardouin P; Delfosse JM; Grimbert I; Truquet B; Hubaud P; Decoulx M; Delcambre B
    Rev Rhum Mal Osteoartic; 1986 Apr; 53(4):243-8. PubMed ID: 3738383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case of pseudohypoparathyroidism type 1b diagnosed as having hypocalcemia].
    Iida S
    Clin Calcium; 2005 Apr; 15(4):689-93. PubMed ID: 15802786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible existence of anti-renal tubular plasma membrane autoantibody which blocked parathyroid hormone-induced phosphaturia in a patient with pseudohypoparathyroidism type II and Sjögren's syndrome.
    Yamada K; Tamura Y; Tomioka H; Kumagai A; Yoshida S
    J Clin Endocrinol Metab; 1984 Feb; 58(2):339-43. PubMed ID: 6319447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.